|
Sign In to gain access to subscriptions and/or personal tools.
|
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE |
Protective and Destructive Immunity in the Periodontium: Part 1—Innate and Humoral Immunity and the Periodontium
Y.-T.A. Teng
Lab. of Molecular Microbial Immunity, Eastman Department of Dentistry, Eastman Dental Center, Box-683, 625 Elmwood Ave., and Centre for Oral Biology, Dept. of Microbiology and Immunology, School of Medicine and Dentistry, The University of Rochester Medical Center, Rochester, NY 14620, USA; andy_teng{at}urmc.rochester.edu
Based on the results of recent research in the field, the present paper will discuss the protective and destructive aspects of the innate vs. adaptive (humoral and cell-mediated) immunity associated with the bacterial virulent factors or antigenic determinants during periodontal pathogenesis. Attention will be focused on: (i) the Toll-like receptors (TLR), the innate immune repertoire for recognizing the unique molecular patterns of microbial components that trigger innate and adaptive immunity for effective host defenses, in some general non-oral vs. periodontal microbial infections; (ii) T-cell-mediated immunity, Th-cytokines, and osteoclastogenesis in periodontal disease progression; and (iii) some molecular techniques developed and used to identify critical microbial virulence factors or antigens associated with host immunity (using Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis as the model species). Therefore, further understanding of the molecular interactions and mechanisms associated with the hosts innate and adaptive immune responses will facilitate the development of new and innovative therapeutics for future periodontal treatments. Abbreviations used in the paper are as follows: A. actinomycetemcomitans (Aa), Actinobacillus actinomycetemcomitans; Ab, antibody; DC, dendritic cells; mAb, monoclonal antibody; pAb, polyclonal antibody; PAMP, pathogen-associated molecular patterns; P. gingivalis (Pg), Porphyromonas gingivalis; and TLR, Toll-like receptors.
Key Words: innate immunity TLR humoral Ig response dendritic cells (DC) pathogen-associated muscular patterns (PAMP)
Journal of Dental Research, Vol. 85, No. 3,
198-208 (2006)
DOI: 10.1177/154405910608500301

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Hasegawa, T. Osaka, K. Tawaratsumida, T. Yamazaki, H. Tada, G. Y. Chen, S. Tsuneda, G. Nunez, and N. Inohara
Transitions in Oral and Intestinal Microflora Composition and Innate Immune Receptor-Dependent Stimulation during Mouse Development
Infect. Immun.,
February 1, 2010;
78(2):
639 - 650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Zhang, M. Alnaeeli, B. Singh, and Y.-T. A. Teng
Involvement of SOCS3 in Regulation of CD11c+ Dendritic Cell-Derived Osteoclastogenesis and Severe Alveolar Bone Loss
Infect. Immun.,
May 1, 2009;
77(5):
2000 - 2009.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Wang, M.-A. K. Shakhatreh, D. James, S. Liang, S.-i. Nishiyama, F. Yoshimura, D. R. Demuth, and G. Hajishengallis
Fimbrial Proteins of Porphyromonas gingivalis Mediate In Vivo Virulence and Exploit TLR2 and Complement Receptor 3 to Persist in Macrophages
J. Immunol.,
August 15, 2007;
179(4):
2349 - 2358.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Burns, G. Bachrach, L. Shapira, and G. Nussbaum
Cutting Edge: TLR2 Is Required for the Innate Response to Porphyromonas gingivalis: Activation Leads to Bacterial Persistence and TLR2 Deficiency Attenuates Induced Alveolar Bone Resorption
J. Immunol.,
December 15, 2006;
177(12):
8296 - 8300.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Carayol, J. Chen, F. Yang, T. Jin, L. Jin, D. States, and C.-Y. Wang
A Dominant Function of IKK/NF-{kappa}B Signaling in Global Lipopolysaccharide-induced Gene Expression
J. Biol. Chem.,
October 13, 2006;
281(41):
31142 - 31151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Zhang and Y.-T. A. Teng
Interleukin-10 Inhibits Gram-Negative-Microbe-Specific Human Receptor Activator of NF-{kappa}B Ligand-Positive CD4+-Th1-Cell- Associated Alveolar Bone Loss In Vivo
Infect. Immun.,
August 1, 2006;
74(8):
4927 - 4931.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|